20
Participants
Start Date
August 1, 2020
Primary Completion Date
August 30, 2021
Study Completion Date
November 1, 2021
Neurotrigger eye blinking stimulator
"Phase 1 - The first stage is composed of a one-time participation for about three hours and involves:~1. Verifying compliance of the patients with the research inclusion and exclusion criteria~2. Completion of the study clinical report form (CRF) for this stage~3. Placement of the single use mini-electrodes that will be adhered to the facial skin near the non-blinking eye and coupled to the Neurotrigger stimulator to elicit eyelid closure.~Participants may be enrolled to the second phase up to one year from the first phase visit In the second stage the duration of the participation is about three weeks (six days a week) and includes daily use of the device for up to 10 hours a day. During nights the patient will continue is standard pattern of either eye closure or leaving the eye open, as the patient used to do prior to the study.~This stage will involve a patient with a partner that is designated to support the patient closely during the placement and adjustment of the system"
Tel Aviv Sourasky Medical Center (Ichilov), Tel Aviv
Lead Sponsor
Tel Aviv Medical Center
OTHER
Neurotrigger Ltd
INDUSTRY